ABS Direct Equity Fund’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
ABS Direct Equity Fund's GH Position: Q2 2026 in Review
ABS Direct Equity Fund reduced its Guardant Health (GH) stake by 93% in Q2 2026, selling an estimated $234K and leaving 150 shares worth $345K. The position accounts for 0.22% of the portfolio, ranked #83.
ABS Direct Equity Fund first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- ABS Direct Equity Fund held 150 shares of Guardant Health worth $345K as of Q2 2026.
- ABS Direct Equity Fund sold 2,150 Guardant Health shares in Q2 2026, an estimated $234K.
- Guardant Health made up 0.22% of ABS Direct Equity Fund's portfolio in Q2 2026, its #83 holding.
- ABS Direct Equity Fund first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on ABS Direct Equity Fund's 13F filing for Q2 2026, filed 13 Aug 2026.